FDA Inspection 1111704 — Sato Pharmaceutical Co., Ltd.
The FDA completed an inspection of Sato Pharmaceutical Co., Ltd. on November 7, 2019 in Hachioji. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2019
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Hachioji (Japan)